Research Article
Public Willingness to Undergo Presymptomatic Genetic Testing for Alzheimer’s Disease
Table 3
Participants’ perception about presymptomatic genetic testing for Alzheimer’s disease (total number of participants =2935).
| Participants’ perception about presymptomatic genetic testing for autosomal dominant AD genes, APOE, or both. | Number (%) |
| Accepting either genetic tests | 1758 (59.9) | Accepting both genetic tests | 1325 (45.1) | Accepting autosomal dominant AD genetic test | 1560 (53.2) | Accepting APOE gene test | 1523 (51.9) | Rejecting both tests | 1177 (40.1) |
|
|